Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DDX56 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | GPRC5D | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | COPRS | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
mRNA | UGT3A2 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
mRNA | CCDC169-SOHLH2 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | EIF4E2 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | ETFA | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
mRNA | GPR148 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | RSBN1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
mRNA | ESYT1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |